KDM5B gene expression was determined in breast cancer patient samples, and the cytotoxic activity and the effect of ABC sensitization on doxorubicin (DOX) were investigated in 2-D and 3-D cultures. This evidence concerns the gene KDM5B and breast carcinoma.